HomeNewsHealthTech For Care and EIT Health Announce Partnership to Support the Acceleration...

HealthTech For Care and EIT Health Announce Partnership to Support the Acceleration of European HealthTech Companies

The first act of this collaboration will be the co-organisation and promotion of the HealthTech Innovation Days (HTID®), an event which fosters collaborations within European healthcare ecosystems in order to accelerate access to medical innovation for all patients.

Paris, May 28, 2020 – HealthTech For Care, a new patient-centred endowment fund designed to promote and accelerate access to care for all patients, and EIT Health, the health community of the European Institute of Innovation and Technology – Health, have announced an institutional partnership. Through this partnership, HealthTech For Care and EIT Health will together co-promote a series of events aimed at meeting the economic and societal challenge of accelerating access to innovative healthcare solutions for all patients. The HealthTech Innovation Days (HTID®) will be the first event and will be held in Paris on October 5th and 6th, 2020.

EIT Health will act as an institutional partner to HTID® and, through such a partnership; participants will have the potential to interact with EIT Health’s extensive network of 150 partners throughout Europe. EIT Health’s access to deep knowledge of the European life science ecosystem will raise awareness and draw more European companies to participate in HTID®. EIT Health will also support and amplify HTID®’s visibility thanks to its pan-European network presence across different European countries.

Thanks to this partnership, HTID® will also provide a venue for future Venture Centre of Excellence (VCoE) in-person members’ meetings. The Venture Centre of Excellence is the first pan-European open innovation platform, currently being co-designed and launched by EIT Health and the European Investment Fund. The VCoE will offer its members access to an exclusive network within which to share deal flow opportunities with selected VC funds from EIF’s network. In turn, this will facilitate co- and direct-investment opportunities in Europe’s most promising Life Science start-ups, thereby supporting European innovation.

“We are thrilled to partner with HealthTech For Care to support the extensive developments taking place in European HealthTech, and to help accelerate this work to improve patient quality of life by promoting HTID® and everything the event stands for. The HTID® is an ideal event at which to bring together new VCoE members and the broader Life Science investment community for the first time. This is especially true as the VCoE’s operational teams will be based in Paris” said Jean-Marc Bourez, Managing Director of EIT Health France and Head of the VCoE.

“The partnership with EIT Health is a fantastic opportunity to build a more connected ecosystem. There are about 30,000 medical technology companies in Europe that are working to develop ground-breaking EIT Health is supported by the EIT, a body of the European Union advances – our goal is to accelerate and support the development of these companies, and help patients get access to these advances,” said Maryvonne Hiance, President of HealthTech For Care.

Jan-Philipp Beck, Chief Executive Officer of EIT Health stated “At EIT Health we have created a fantastic ecosystem that connects over 150 top players from across Europe representing excellence in health innovation. We are set up to deliver new innovations and contribute to the re-imagining of European healthcare systems for their long-term sustainability. Partnering with HealthTech For Care to hold and co-organise the HTID event is an amazing opportunity to host the first bi-annual Venture Centre of Excellence members’ meeting. This connection with the EIF, the largest investor in European life science venture capital and the sector’s most active limited partner with ~ EUR 2bn in commitments, close to 100% market coverage and an annual volume of around EUR 300m, is a tremendous opportunity to mobilise the investment needed to scale.”

For more information, please visit: http://www.htid-paris.com.

About HealthTech For Care

The HealthTech For Care endowment fund is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. The missions of the endowment fund are structured around three main areas: Supporting the development of the entire health ecosystem, accelerating the development of innovative therapies and treatments, and promoting better access to healthcare for patients in the French healthcare system and more widely throughout Europe. HealthTech For Care is administrated by Maryvonne Hiance, Elsy Boglioli, David Caumartin, Pierre Courteille, Eric Falcand, Marc Le Bozec, Cédric Moreau, Franck Mouthon, Christian Pierret and Christian Policard.

About EIT Health

Established in 2015, EIT Health is a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). EIT Health promotes entrepreneurship and innovation in healthy living and active ageing by providing Europeans with new opportunities and resources. It enables citizens to lead healthier and more productive lives by delivering products, services and concepts that improve quality of life and contribute to the sustainability of healthcare across Europe. For more information, please visit: www.eithealth.eu.

About EIF

The European Investment Fund (EIF) is part of the European Investment Bank group. Its central mission is to support Europe’s micro, small and medium-sized businesses (SMEs) by helping them to access finance. EIF designs and develops venture and growth capital, guarantees and microfinance instruments that specifically target this market segment. In this role, EIF fosters EU objectives in support of innovation, research and development, entrepreneurship, growth, and employment. For more information visit: www.eif.org

About HTIDÒ

Following the success of HTID’s first edition in 2019, in which featured the participation of EIT Health alongside many other important partners, the purpose of this second event in 2020 is to drive and foster collaborations within the European healthcare and life sciences ecosystems. The HealthTech Innovation Days brings the European healthcare community together to discuss new trends in research & development. This symposium also features conferences and panel discussions, networking and private meetings between innovative European HealthTech companies, pharmaceutical companies, life sciencesspecialized investors, healthcare experts, KOLs and institutional representatives. In addition to the ongoing private networking, attendees can expect roundtables focused on critical economic and political issues that impact health technology developments. The HealthTech Innovation Days are intended for publicly listed companies whose market capitalization is at least €20 million, or for privately held biotech firms whose drug candidates are currently undergoing late Phase I studies. For MedTech companies, medical devices must have already obtained the CE mark in Europe or FDA approval in the United States.  2020 will be held on October 5ÒDetails of the roundtables will be announced in the coming weeks. HTID & 6 in Paris. http://www.htid-paris.com/

Press Contacts

HTID

Nathalie Donne
nathalie.donne@shapenlink.com
+33(0)6 67 67 44 97

EIT Health
Jérôme Fabiano
jerome.fabiano@eithealth.eu

RooneyPartners LLC – NORTH AMERICA
Kate Barrette
kbarrette@rooneyco.com
+1.212.223.0561

StrategiesImage (S&I) – FRANCE
Anne Rein
anne.rein@strategiesimage.com
+33(0)6 03 35 92 05

MC Services AG – GERMANY
Anne Hennecke
Anne.hennecke@mc-services.eu
+49 211 529 252 22

Must Read

Related News